HOOD:NASDAQRobinhood Markets, Inc. Analysis
Data as of 2026-07-18 - not real-time
$99.96
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Robinhood (HOOD) is trading at $99.96, well below its 20‑day SMA of $107.29, indicating short‑term weakness. The 50‑day SMA sits at $93.02, so the stock remains above that longer‑term support, creating a mixed moving‑average picture. Technical momentum is bearish, with the MACD histogram at –1.50 and a “bearish” signal line crossover. RSI at 46.6 suggests the stock is neither oversold nor overbought, reinforcing a neutral stance. Volume has been decreasing, hinting at waning buying pressure despite a recent 17% monthly gain. The market’s “Extreme Greed” sentiment (fear‑greed index 87.9) may be inflating price expectations.
Fundamentally, HOOD posts 15% revenue growth, a 92% gross margin and a 38% operating margin, underscoring a high‑margin business model. However, the forward PE of 32.5 versus an industry average of 17.8, and a DCF fair value of $63.73, signal that the stock is significantly overvalued. The company carries a heavy debt load (debt‑to‑equity >140) and a beta above 3, exposing it to market swings and financial risk. Upcoming Q2 earnings on July 29 could clarify whether growth can sustain the lofty valuation. Recent positive news—such as a Goldman Sachs target raise and a new blockchain launch—has helped the stock rally to $115 in recent sessions. Investors should weigh the strong margins and cash position against the regulatory headwinds and valuation gap before committing capital.
Fundamentally, HOOD posts 15% revenue growth, a 92% gross margin and a 38% operating margin, underscoring a high‑margin business model. However, the forward PE of 32.5 versus an industry average of 17.8, and a DCF fair value of $63.73, signal that the stock is significantly overvalued. The company carries a heavy debt load (debt‑to‑equity >140) and a beta above 3, exposing it to market swings and financial risk. Upcoming Q2 earnings on July 29 could clarify whether growth can sustain the lofty valuation. Recent positive news—such as a Goldman Sachs target raise and a new blockchain launch—has helped the stock rally to $115 in recent sessions. Investors should weigh the strong margins and cash position against the regulatory headwinds and valuation gap before committing capital.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below 20‑day SMA
- bearish MACD crossover
- declining volume trend
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- 15% revenue growth
- high gross and operating margins
- analyst consensus buy and target price above current
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- elevated debt‑to‑equity ratio
- high beta and market volatility
- regulatory uncertainty in fintech sector
Key Metrics & Analysis
Financial Health
Revenue Growth15.10%
Profit Margin41.12%
P/E Ratio51.5
ROE21.46%
ROA5.19%
Debt/Equity140.48
P/B Ratio9.7
Op. Cash Flow$3.0B
Industry P/E17.8
Technical Analysis
TrendNeutral
RSI46.6
Support$92.80
Resistance$120.05
MA 20$107.29
MA 50$93.02
MA 200$101.75
MACDBearish
VolumeDecreasing
Fear & Greed Index87.91
Valuation
Fair Value$63.73
Target Price$118.28
Upside/Downside18.33%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.05
Volatility72.23%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.